NICE HealthTech Guidance

• Richard Tuson
• /
• 11 Feb 2026

Faster, Fairer Access to HealthTech: Transforming Innovation in the NHS

Healthcare technology is advancing rapidly, offering new opportunities to improve diagnosis, treatment, and patient outcomes.

However, one long-standing challenge has been ensuring that innovative medical technologies reach NHS patients quickly and consistently across the country.

To address this, NICE has launched a new national initiative designed to accelerate the adoption of high-impact health technologies within the NHS.

The National HealthTech Access Programme (NHAP) aims to ensure that effective medical devices, diagnostics, and digital tools can be adopted more quickly and equitably across the health system.

Watch the video above to learn more about the programme, why it matters for healthcare innovation, and how it could transform patient access to life-saving technologies.

What Is the National HealthTech Access Programme?

The National HealthTech Access Programme is a new initiative designed to give patients faster and fairer access to innovative health technologies across England and Wales.

Historically, new medical technologies have often reached NHS patients slowly or unevenly, with access sometimes varying between regions.

The new programme aims to address this by expanding NICE’s established Technology Appraisal framework, which has traditionally focused on medicines, to also include medical devices, diagnostics, and digital health technologies.

This means that selected high-impact technologies can be evaluated and, if proven clinically and cost effective, reimbursed and adopted consistently across the NHS.

The programme is a collaboration between several national organisations, including:

• NICE
• NHS England
• The Department of Health and Social Care
• The Medicines and Healthcare products Regulatory Agency (MHRA)
• The Office for Life Sciences

Together, these organisations are working to create a more streamlined pathway for HealthTech innovation to reach patients.

Why This Programme Matters

Health technologies, including AI tools, diagnostic devices, and digital health platforms — have the potential to transform healthcare delivery.

However, innovators have often faced challenges navigating the complex pathways required to bring new technologies into routine NHS use.

The National HealthTech Access Programme aims to solve this by providing:

• A clearer national route for adoption of innovative technologies
• More consistent access to approved technologies across regions
• Faster patient access to clinically proven innovations

When NICE was first established, its goal was to eliminate the “postcode lottery” in access to medicines. The new programme extends this principle to HealthTech, ensuring that clinically effective technologies can be made available consistently across the NHS.

Ultimately, the initiative is designed to ensure NHS resources are directed toward technologies that deliver the greatest benefit for patients and the healthcare system.

Early Technologies in the Programme

The first technologies entering the programme demonstrate the potential impact of innovative diagnostics and AI tools.

One example is the capsule sponge test, sometimes described as a “pill on a string”, used to detect abnormal cells linked to Barrett’s oesophagus and early oesophageal cancer.

The patient swallows a small capsule containing a compressed sponge. Once the capsule dissolves in the stomach, the sponge expands and is gently withdrawn using a string, collecting cells from the oesophagus for analysis.

This approach provides a less invasive alternative to endoscopy and can help detect early signs of cancer while freeing up capacity in hospital diagnostic services.

Another technology being evaluated involves AI tools that analyse images of tissue samples to support cancer diagnosis, particularly in prostate and breast cancer pathways.

These tools can help pathologists identify suspicious regions in tissue images, prioritise high-risk cases, and reduce routine workload, supporting faster diagnosis and more efficient care pathways.

Additional technologies are also being considered, including tools that could help detect endometrial cancer and AI systems to analyse chest X-rays for suspected lung cancer in primary care referrals.

Supporting Innovation Across the NHS

The National HealthTech Access Programme forms part of a broader strategy within the government’s 10 Year Health Plan to modernise the NHS and unlock the potential of new technologies.

By creating a more transparent and predictable pathway for HealthTech adoption, the programme aims to support:

• Faster diagnosis for serious conditions such as cancer
• Reduced pressure on NHS diagnostic services
• Improved efficiency for clinicians
• More equitable access to innovative technologies across the country

For MedTech innovators, the programme also provides a clearer pathway to national adoption, reducing the need for region-by-region implementation strategies.

The Future of HealthTech Innovation

The introduction of the National HealthTech Access Programme marks an important step in strengthening the UK’s HealthTech ecosystem.

By bringing together regulators, healthcare providers, and innovators, the programme aims to ensure that promising technologies can move more efficiently from development into real-world clinical use.

At Health Analytical Solutions, we recognise the critical role innovation plays in improving healthcare delivery and patient outcomes.

By working collaboratively with healthcare organisations, researchers, and technology developers, we aim to support the identification and development of solutions that can help transform care pathways across the NHS.

If you are developing technologies that could support diagnostics, digital health, or AI-driven clinical tools, we encourage you to connect with us at enquiry@healthanalyticalsolutions.co.uk to explore opportunities for collaboration.

Innovation starts with access and initiatives like the National HealthTech Access Programme are helping ensure that the best technologies reach the patients who need them most.